赛乐西帕 | 司来帕格
NS-304 (Selexipag; ACT-293987)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg
Product Availability
3-5days
Price
$100.00
Member price
Product Availability
3-5days
Price
$125.00
Member price
Product Availability
3-5days
Price
$200.00
Member price
Quantity
- +
Product Overview
Product Name NS-304 (Selexipag; ACT-293987)
CAS475086-01-2
FormulaC26H32N4O4S
MW496.62
Appearance White to yellow powder
Security information
Product details

Selexipag, also known as ACT-293987 and NS-304, is a a first-in-class orally available selective non-prostanoid IP receptor agonist, which is currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT-333679, are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation.

Related literature
Related
Sorry, no related items
History
Midostaurin | PKC412 | CGP 41231 | CGP 41251
24, 25-Dihydroxy VD2; 24,25-Dihydroxy vitamin D2;24,25-Dihydroxyvitamin D2; (4E,6R)-2,3-Dimethyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-4-heptene-2,3-diol
Photochlor(HPPH); HPPH
Mifamurtide | CGP-19835| MTP-PE | L-MTP-PE
NS-304 (Selexipag; ACT-293987)
ALM301
(S)-Tenofovir (Synonyms:(S)-GS 1278; (S)-PMPA; (S)-TDF)
Lenacapavir (Synonyms: GS-6207)
PT-2385
Asciminib (Synonyms: ABL001)